Kyle Quinn

Title: Innovations by Inventor Kyle Quinn

Introduction

Kyle Quinn is a notable inventor based in Fayetteville, Arkansas, with a focus on advancements in cellular and tissue assessment technologies. He holds a total of five patents that showcase his innovative contributions to the field of biomedical engineering.

Latest Patents

One of his latest patents is titled "System and method for assessing cellular metabolic activity." This invention involves methods and corresponding apparatus for assessing cellular metabolic activity by illuminating cells with optical radiation. The process causes multi-photon excitation of endogenous metabolic cofactors, leading to the emission of fluorescent radiation. A detector captures this radiation, and a computer processor analyzes it to derive parameters that assess metabolic processes within the cell.

Another significant patent is the "Contactless system and method for assessing tissue viability and other hemodynamic parameters." This invention features a contactless system that utilizes light sources emitting at specific wavelengths sensitive to hemoglobin concentration. The system assesses tissue viability by analyzing spontaneous hemodynamic oscillations. It includes a controller that processes data to generate a two-dimensional hemodynamic map, indicating the strength of blood volume oscillations and tissue viability.

Career Highlights

Kyle Quinn has worked with reputable institutions, including Tufts College and Vivonics, Inc. His experience in these organizations has contributed to his expertise in developing innovative technologies that enhance biomedical assessments.

Collaborations

Throughout his career, Kyle has collaborated with notable colleagues, including Irene Georgakoudi and Dimitra Pouli. These collaborations have further enriched his research and development efforts in the field.

Conclusion

Kyle Quinn's contributions to the field of biomedical engineering through his patents and collaborations highlight his commitment to innovation. His work continues to pave the way for advancements in cellular and tissue assessment technologies.